Stroke
From the Journals
Mobile stroke teams treat patients faster and reduce disability
A pilot program in New York City found that patients treated by a mobile interventional stroke team received care sooner and were more likely to...
News
FDA panel balks at TriGuard 3 cerebral embolic device for TAVR
The device offers advantages over the approved Sentinel device but could not tamp down stroke rates, the very complication it was designed to...
From the Journals
Intracranial atherosclerosis finding on MRA linked to stroke
An incidental diagnosis of intracranial atherosclerotic stenosis in stroke-free individuals should trigger a thorough assessment of vascular...
Conference Coverage
DOACs best aspirin after ventricular ablation: STROKE-VT
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial and may yet be further improved....
From the Journals
Direct oral anticoagulants: Competition brought no cost relief
Medicare Part D spending since 2011 has far outpaced growth in the use of oral anticoagulants.
Conference Coverage
Younger adults with HIV have higher CVD risk but low ASCVD scores
From the Journals
Statins again linked to lower COVID-19 mortality
Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t...
From the Journals
Five risk factors may predict thrombus on LAA occlusion implants
With a new clinical risk score, patients deemed at high risk showed a twofold increased rate of this worrisome complication.
Conference Coverage
Testosterone replacement shows CV benefit in hypogonadal men
Among men with hypogonadism who received testosterone replacement every 3 months, cardiovascular parameters were better and there were fewer...
From the Journals
CABANA: Ablation bests drugs for AFib in racial/ethnic minorities
A new secondary analysis points to a large relative advantage of ablation and worse outcomes with drug therapy in North American minority patients...
From the Journals
Midlife change in wealth may be costly for heart health
In a longitudinal analysis, the long-term risk of cardiovascular disease was linked to wealth mobility from ages 50 to 64.